Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilson H Miller

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Oncogene|July 27, 2004
Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERKFilippa Pettersson, Marie-Claude Couture, Nessrine Hanna, et al.
Blood|January 1, 2004
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cellsKelly Davison, Koren K Mann, Samuel Waxman, et al.
Best Practice & Research. Clinical Haematology|November 1, 2003
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemiaFrancesco Lo-Coco, Massimo Breccia, Nélida Noguera, et al.
Journal for Immunotherapy of Cancer|January 28, 2022
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibitionMeagan-Helen Henderson Berg, Sonia Victoria Del Rincón, Wilson H Miller
Journal of Neurochemistry|April 9, 2005
Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disordersZuanel Diaz, Michael I Assaraf, Wilson H Miller, et al.
Endocrinology|February 15, 2003
Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cellsRoberto Lin, Tian Tian Wang, Wilson H Miller, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Real-World Outcomes of Incurable Cancer Patients Treated with Unlisted Anticancer Treatments in an Academic Center in Quebec, CanadaAdam Miller, Francois Panet, Victoria Korsos, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu PrebioticSteph A Pang, Arielle Elkrief, Mariana Pilon Capella, et al.
Expert Opinion on Investigational Drugs|September 29, 2009
Darinaparsin: a novel organic arsenical with promising anticancer activityKoren K Mann, Barbara Wallner, Izidore S Lossos, et al.
Oncogene|May 31, 2003
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathwaySonia V del Rincón, Caroline Rousseau, Ratna Samanta, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Oncogene|July 27, 2004
Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERKFilippa Pettersson, Marie-Claude Couture, Nessrine Hanna, et al.
Blood|January 1, 2004
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cellsKelly Davison, Koren K Mann, Samuel Waxman, et al.
Best Practice & Research. Clinical Haematology|November 1, 2003
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemiaFrancesco Lo-Coco, Massimo Breccia, Nélida Noguera, et al.
Journal for Immunotherapy of Cancer|January 28, 2022
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibitionMeagan-Helen Henderson Berg, Sonia Victoria Del Rincón, Wilson H Miller
Journal of Neurochemistry|April 9, 2005
Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disordersZuanel Diaz, Michael I Assaraf, Wilson H Miller, et al.
Endocrinology|February 15, 2003
Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cellsRoberto Lin, Tian Tian Wang, Wilson H Miller, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Real-World Outcomes of Incurable Cancer Patients Treated with Unlisted Anticancer Treatments in an Academic Center in Quebec, CanadaAdam Miller, Francois Panet, Victoria Korsos, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu PrebioticSteph A Pang, Arielle Elkrief, Mariana Pilon Capella, et al.
Expert Opinion on Investigational Drugs|September 29, 2009
Darinaparsin: a novel organic arsenical with promising anticancer activityKoren K Mann, Barbara Wallner, Izidore S Lossos, et al.
Oncogene|May 31, 2003
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathwaySonia V del Rincón, Caroline Rousseau, Ratna Samanta, et al.
Pageof 17